Matches in Nanopublications for { ?s ?p "[HLA-A*2402 was increased among patients with interferon-associated type 1 diabetes compared with those without diabetes, despite interferon therapy (odds ratio [OR] 4.00 [95% CI 1.09-17.26]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- assertion description "[HLA-A*2402 was increased among patients with interferon-associated type 1 diabetes compared with those without diabetes, despite interferon therapy (odds ratio [OR] 4.00 [95% CI 1.09-17.26]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[HLA-A*2402 was increased among patients with interferon-associated type 1 diabetes compared with those without diabetes, despite interferon therapy (odds ratio [OR] 4.00 [95% CI 1.09-17.26]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[HLA-A*2402 was increased among patients with interferon-associated type 1 diabetes compared with those without diabetes, despite interferon therapy (odds ratio [OR] 4.00 [95% CI 1.09-17.26]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP527999.RA1WbNr-nx7zDNVuR7-ryP8UpzBi21l10Wqw5SHE57yUo130_assertion description "[HLA-A*2402 was increased among patients with interferon-associated type 1 diabetes compared with those without diabetes, despite interferon therapy (odds ratio [OR] 4.00 [95% CI 1.09-17.26]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527999.RA1WbNr-nx7zDNVuR7-ryP8UpzBi21l10Wqw5SHE57yUo130_provenance.
- NP614560.RA8XOQmQMKoSIVdZpVL9Nef6JMkPjPNgHhWPP-XPxrYVw130_assertion description "[HLA-A*2402 was increased among patients with interferon-associated type 1 diabetes compared with those without diabetes, despite interferon therapy (odds ratio [OR] 4.00 [95% CI 1.09-17.26]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614560.RA8XOQmQMKoSIVdZpVL9Nef6JMkPjPNgHhWPP-XPxrYVw130_provenance.
- NP450752.RAS4suJSyGUbMBeaPP67E66YRISqQSNCwj9GDXOiwMGno130_assertion description "[HLA-A*2402 was increased among patients with interferon-associated type 1 diabetes compared with those without diabetes, despite interferon therapy (odds ratio [OR] 4.00 [95% CI 1.09-17.26]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450752.RAS4suJSyGUbMBeaPP67E66YRISqQSNCwj9GDXOiwMGno130_provenance.
- NP450759.RAXU_Ro0hPNsTxs3isPWrzGWnEhDmp6exHiwL1qgnO91w130_assertion description "[HLA-A*2402 was increased among patients with interferon-associated type 1 diabetes compared with those without diabetes, despite interferon therapy (odds ratio [OR] 4.00 [95% CI 1.09-17.26]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450759.RAXU_Ro0hPNsTxs3isPWrzGWnEhDmp6exHiwL1qgnO91w130_provenance.
- NP868019.RAbZumexdDfV6G5T_Ak1hOunRd1iUX3ZHlMDXjkSuuh1A130_assertion description "[HLA-A*2402 was increased among patients with interferon-associated type 1 diabetes compared with those without diabetes, despite interferon therapy (odds ratio [OR] 4.00 [95% CI 1.09-17.26]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868019.RAbZumexdDfV6G5T_Ak1hOunRd1iUX3ZHlMDXjkSuuh1A130_provenance.
- NP450742.RApG1Duce5gKI3mFW-Pek7iKE9L6oHxrTt15xPx2smqoQ130_assertion description "[HLA-A*2402 was increased among patients with interferon-associated type 1 diabetes compared with those without diabetes, despite interferon therapy (odds ratio [OR] 4.00 [95% CI 1.09-17.26]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450742.RApG1Duce5gKI3mFW-Pek7iKE9L6oHxrTt15xPx2smqoQ130_provenance.
- NP868018.RAhL8vJieLjR7HYzDc-okSOvogYC4VF3zRbVbDWzckSJ4130_assertion description "[HLA-A*2402 was increased among patients with interferon-associated type 1 diabetes compared with those without diabetes, despite interferon therapy (odds ratio [OR] 4.00 [95% CI 1.09-17.26]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868018.RAhL8vJieLjR7HYzDc-okSOvogYC4VF3zRbVbDWzckSJ4130_provenance.
- NP868017.RAFq4dsc1YxWXHPHfWow0iftiT0oivpW2AFwvyuPrgoTE130_assertion description "[HLA-A*2402 was increased among patients with interferon-associated type 1 diabetes compared with those without diabetes, despite interferon therapy (odds ratio [OR] 4.00 [95% CI 1.09-17.26]).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868017.RAFq4dsc1YxWXHPHfWow0iftiT0oivpW2AFwvyuPrgoTE130_provenance.